Abstract
D&MD' s new market analysis report - Impact of Nano Materials in Drug Delivery & Human Tissue Engineering - provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen their capabilities and provides a description of the product' s market niche to pinpoint future trends. A recent analysis of more than 200 commercially available products that use nano-based technological enhancements in the pharmaceutical, medical or healthcare field is reinforcing the notion that "incremental" modifications of existing drugs, drug delivery devices and tissue engineering products enhanced by nano innovations is beginning to harvest revenue.
Table of Contents
Chapter 1: Executive Summary
Chapter 2: Nanomaterials Relating to the Drug Discovery, Drug Delivery & Tissue Engineering Industries
- Nanoparticles
- Quantum Dots (QDs)
- Gold Colloids
- Gold & Quantum Dots for Molecular Diagnostics
- Magnetic Nanoparticles
- Dendrimers
- Nanoshells
- Carbon Nanotubes & Nanotube Matrices
- Multiplex Molecular Tagging with QDs, Nanotags, and Nanoprisms
- Nanobarcodes
- Biobarcode Assay for Proteins
- Nanoparticle-based Colorimetric DNA Detection Method
- Liposomes
- Multilayered Nanoparticles
- New MRI Nanomaterials as Probes for Imaging Agents-Gadolinium in
Fullerenes & Quantum Dots
- Molecular Imaging
- Drug Delivery and Therapeutics-Bioavailability through Nanocrystals
- Rexin G-An FDA Approved Targeted Delivery System (TDS)
- Nanocrystals in Immunohistochemistry & Nanomedicine
- Fullerenes for Delivering Therapeutic Molecules
- Injectable & Topical Platforms Enhanced by Nanoparticluate Technologies
- Nanotechnologies with Biochips & Protein chips
- Nano Biosensors
- Nanowire Biosensors using Boron-doped Silicon Nanowire
- Viral Nanosensor
- Probes Encapsulated by Biologically Localized Embedding Nanosensors
- New Nano-based Biosensor Technologies in Market
- Nano Tissue Engineering-Nanophase Biomaterials
- Biocompatible Polymer Nanofibers
- Nanochemicals Against Cancer
- Nanodrugs and Companies Targeting Cancer
- Nanobiotechnology' s Contributions to the Pharmaceutical/Medical Sectors
Chapter 3: Commercial Pharmaceutical & Tissue Engineering Product Applications Using Nano Materials
- Nano Technology and the Pharmaceutical/Tissue Engineering
- Product Applications Market in 2005
- Nanoengineering and Emerging Nanotechnology
- Nanoparticles
- Carbon Nanoparticles and Nanotubes Market
- Medical & Healthcare Diagnostic Devices Markets
- Reporter Molecules and Molecular Tags for Biomolecular Detection
- Biosensors
- Contrast and Imaging Agents for MRI and PET
- Nanobiotechnology Utility in the Drug Discovery and Delivery Process
- Solubilizing Pre-existing Drugs and Enhancing Controlled Drug Delivery
- Improved Drug Formulations
- Controlled Released Drugs
- Multifunctional Drug Delivery Platforms
- Targeted Drug Delivery Platforms
- Targeted Drug Delivery
- Devices for Targeted Drug Delivery
- Medical & Tissue Engineering Nano Material-based Products in 2005
- Wound Dressings and Wound Repair
- Stents and Catheters
- Implants and Prosthetics
- Future Markets of Pharmaceutical and Medical
- "Nano Material-based" Products
- Ongoing Clinical Trials using Nano material-based drugs
- National Nanotechnology Advisory Panel Evaluation of the US Nano
- Sector Markets
Chapter 4: Health, Environmental, and Societal Impacts of Nanoparticles
- Free Nanoparticles
- Free Nanoparticle Safety Needs To Be Assessed
- Potential Exposure Routes
- Nanoparticles Can Be Toxic by Inhalation or through Skin Exposure
- Factors Affecting Deleterious Effects of Nanomaterials
- Eco-toxicity-On the Environment and on Other Species
- Possible Adverse Health Issues
- Regulatory Issues of Nanotechnology
- Royal Society & Royal Academy of Engineering July 2004 UK Report
- The US FDA
- Future Considerations
- Social Science Issues
- Societal Impacts
- Personal Safety versus Covert Surveillance
- Is the Science Fiction Larger than the Science of Nanotechnology?
Chapter 5: Global Investments by Private and Federal Resources
- Private Funding Accounts for Almost 40-50 % of Investment in the Nanotechnology Sector
- Global Distribution of Funding Sources of Nanotechnology
- Private Venture Capital Funding in the US Market
- Similarities between Nanotechnology, Semiconductor Industry, and DNA Technologies
- Patents as Indicators of the Maturity of Nanotech Investments
- Big Pharma' s Stumbling Block-dying Patents
- Global Distribution of Patents and Academic Publications in Nano Areas-
- The Rise of China
- World Leaders in Nano Investment-US, Japan, EU & China
- United States has invested $4.7 Billion Since 2001
- Japan Spent $800 Million for Nanobiotechnology In 2005
- China will have Invested $600 Million by 2007
- Investments by Other Asian Countries
- $1 Billion from Germany, France UK & Sweden
- Nanotechnology Global Investment was Approximately $9 Billion in 2005
Chapter 6: Nanobiotechnology Companies
- Nano Material Manufacturing Companies to Watch
- Dendrimer, Fullerene & Nanotube-based Companies
- Nano Arrays & Molecular Tag Companies
- List of Nanobiotechnological Companies
